# Medpace Holdings, Inc. (MEDP): Undervalued CRO or Funding-Dependent Risk?

Page: https://stenobird.com/podcast/stock-spotlight-7027390/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk
Text version: https://stenobird.com/podcast/stock-spotlight-7027390/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk.md
Podcast: [Stock Spotlight](https://stenobird.com/podcast/stock-spotlight-7027390)
Published: 2025-04-02T13:30:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/mf369/episodes/Medpace-Holdings--Inc--MEDP-Undervalued-CRO-or-Funding-Dependent-Risk-e30g7ii
Audio file: https://anchor.fm/s/fa8f9bac/podcast/play/100195346/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-2-21%2F721c223a-12e9-88bd-de63-77eb3b792adc.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/stock-spotlight-7027390/episodes/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk
Duration seconds: 2711

## Resource

On this episode of Stock Spotlight, Michael analyzes Medpace Holdings (MEDP), a unique player in the contract research organization (CRO) space. Unlike industry giants focused on big pharma, Medpace specializes in small to mid-sized firms - a double-edged sword that grants pricing power, but also exposes it to biotech funding volatility. With a potential return to double-digit growth in 2026, Medpace meets the criteria for a Quality Growth company, but its narrow moat, lack of true market leadership and poor Glassdoor ratings raise red flags. From a valuation standpoint, Medpace appears modestly undervalued, yet technical indicators signal caution. Is Medpace a hidden gem in the healthcare sector or a high-risk bet reliant on biopharma funding stability? Tune in as Michael unpacks his strategy for this niche CRO. ---------------------------------------------------------------- 00:00 Intro 00:38 Investment Checklist & Database 02:31 Business & Industry Overview 13:23 Business Model & Quality Growth Attributes 22:19 Financial Statement Overview 30:05 Management & Ownership Structure 34:48 Growth Areas & Risk Factors 37:46 KPIs to Track 38:43 Valuation & Technical Analysis 43:46 Episode Takeaways 44:36 Outro ---------------------------------------------------------------- Intro Music: Andrey Rossi – Seize the Day Outro Music: Ra – Prospect *Music provided by Uppbeat Premium Follow me on X: https://twitter.com/invest091 Subscribe to my YouTube channel: https://www.youtube.com/@stockspotlightpodcast ---------------------------------------------------------------- Disclosure: The host of Stock Spotlight is not a licensed financial advisor. The information and opinions shared during the show are for entertainment purposes only.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/stock-spotlight-7027390/episodes/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/stock-spotlight-7027390/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.